Industry workshop
Unlocking Potential: The Essential Role of Implementation Science in the Pharmaceutical Industry
Thursday, 7 November 2024, 14:30-16:00
The workshop is open to academics and practitioners!
Moderators: Skip (Melvin) Olson (Olson Strategies) & Sabina De Geest, University of Basel, Switzerland
14:30-15:00: PRESENTATION: Introduction to Implementation Science in the Pharmaceutical Industry: what is it, its value, and how to make it happen
15:00-16:00: ROUNDTABLE DISCUSSION
The workshop will address the following questions:
(1) The benefit of implementation science to the pharmaceutical industry is easy to quantify but how can industry embrace it?
(2) Should the “Science” be removed from “Implementation Science” to make things simpler (and quicker)?
(3) Can academia collaborate on new approaches to implementation science for pharma that are more approachable and easier to implement? Are they needed?
Melvin “Skip” Olson, ScD
Skip Olson is the Founder of Olson Strategies and focuses on using his 30 years of experience in the pharmaceutical industry to develop strategies and solutions on topics related to Evidence and Implementation Science. He was recently the Global Head of Integrated Evidence Strategy and Innovation at Novartis where he was responsible for promoting the very best in research methodology and applications of Real World and other Evidence across all therapeutic areas and around the globe to drive better decision making. He comes from a background in HE&OR where he has led the use of RWE to transform the generation of patient insights and value for money assessments. He earned a ScD in Biostatistics from Harvard University.
Sabina De Geest , PhD, RN
Sabina De Geest is a Professor of Nursing at the University of Basel's Faculty of Medicine in Switzerland and a part-time Professor at KU Leuven in Belgium. She holds adjunct faculty positions at Johns Hopkins University, the University of Pittsburgh, and New York University. Dr. De Geest leads the PIONEER international group, which focuses on behavioral and psychosocial issues in chronic illnesses. Her research aims to develop, implement, and evaluate innovative care models utilizing eHealth, driven by implementation science methods. Additionally, she co-founded the Swiss Implementation Science Network (https://impact-dph.unibas.ch/).
